Your account is not claimed yet. You can sign up with ORCID to claim your account.

Martin F Fromm (Jörg König)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Venues

Pharmaceutics

Clinical pharmacology and therapeutics

International journal of molecular sciences

Metabolites

Max Planck Institute of Biophysics (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Max Planck Institute of Biophysics

Germany

PHD

Publications

Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Fabian Graßl, Leonard Bock, Álvaro Huete-Huerta González, Martin Schiller, Peter Gmeiner, Martin F Fromm, Martin F Fromm, Harald Hübner, Markus R Heinrich
Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists. Journal of medicinal chemistry (2023)
Bastian Haberkorn, Dennis Löwen, Lukas Meier, Martin F Fromm, Martin F Fromm
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines. Pharmaceutics 15 (3) (2023)
Fabian Müller, Kathrin Hohl, Sascha Keller, Sven Schmidt-Gerets, Birgit Deutsch, Annette Schuler-Metz, Martin F Fromm, Peter Stopfer, Arne Gessner
N 1 -methylnicotinamide as biomarker for MATE-mediated renal drug-drug interactions: impact of cimetidine, rifampin, verapamil, and probenecid. Clinical pharmacology and therapeutics (2023)
Daniela B Surrer, Martin F Fromm, Renke Maas, Martin F Fromm
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact. Metabolites 12 (4) (2022)
Melanie I Then, Thomas Tümena, Anna Sledziewska, Karl-Günter Gaßmann, Renke Maas, Martin F Fromm
Development in prescriptions of contraindicated and potentially harmful QT interval prolonging drugs in a large geriatric inpatient cohort from 2011 to 2021. Clinical pharmacology and therapeutics (2022)
Muhammad Erfan Uddin, Eric D Eisenmann, Yang Li, Kevin M Huang, Dominique A Garrison, Zahra Talebi, Alice A Gibson, Yan Jin, Mahesh Nepal, Ingrid M Bonilla, Qiang Fu, Xinxin Sun, Alec Millar, Mikhail Tarasov, Christopher E Jay, Xiaoming Cui, Heidi J Einolf, Ryan M Pelis, Sakima A Smith, Przemysław B Radwański, Douglas H Sweet, Martin F Fromm, Martin F Fromm, Cynthia A Carnes, Shuiying Hu, Alex Sparreboom
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. International journal of molecular sciences 23 (15) (2022)
Grit Zahn, Diana M Willmes, Nermeen N El-Agroudy, Christopher Yarnold, Richard Jarjes-Pike, Sabine Schaertl, Kay Schreiter, Wiebke Gehrmann, Andrea Kuan Cie Wong, Tommaso Zordan, Martin F Fromm, Jens Jordan, Andreas L Birkenfeld
A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity. Metabolites 12 (8) (2022)
Georg Sebastian Hönes, Ramona Gowry Sivakumar, Christoph Hoppe, Martin F Fromm, Dagmar Führer, Lars Christian Moeller
Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196. International journal of molecular sciences 23 (22) (2022)
Katharina Halbach, Silke Aulhorn, Oliver Jens Lechtenfeld, Marion Lecluse, Sophia Leippe, Thorsten Reemtsma, Bettina Seiwert, Stephan Wagner, Martin F Fromm, Till Luckenbach
Zebrafish Oatp1d1 Acts as a Cellular Efflux Transporter of the Anionic Herbicide Bromoxynil. Chemical research in toxicology 35 (2) (2022)
Shingen Misaka, Yuko Ono, Regina Verena Taudte, Eva Hoier, Hiroshi Ogata, Tomoyuki Ono, Martin F Fromm, Hiroshi Watanabe, Martin F Fromm, Kenju Shimomura
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers. Clinical pharmacology and therapeutics 112 (3) (2022)
Anne T Nies, Martin F Fromm, Ute Hofmann, Charlotte Kölz, Martin F Fromm, Matthias Schwab
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters. Pharmaceutics 13 (3) (2021)
Sofna Banjarnahor, Roman N Rodionov, Martin F Fromm, Renke Maas
Transport of L-Arginine Related Cardiovascular Risk Markers. Journal of clinical medicine 9 (12) (2020)
Emir Taghikhani, Renke Maas, Regina Verena Taudte, Arne Gessner, Martin F Fromm, Martin F Fromm
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells. Amino acids 52 (6-7) (2020)
Emir Taghikhani, Renke Maas, Martin F Fromm, Martin F Fromm
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine. PloS one 14 (3) (2019)
Birgit Deutsch, Claudia Neumeister, Ulrich Schwantes, Martin F Fromm, Martin F Fromm
Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium. Molecular pharmaceutics 16 (2) (2019)

Martin F Fromm.css-eqlu8i{font-size:small;padding-left:4px;} (Jörg König)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin F Fromm (Jörg König)